Grønningsæter, I.S.; Reikvam, H.; Aasebø, E.; Bartaula-Brevik, S.; Hernandez-Valladares, M.; Selheim, F.; Berven, F.S.; Tvedt, T.H.; Bruserud, Ø.; Hatfield, K.J.
Effects of the Autophagy-Inhibiting Agent Chloroquine on Acute Myeloid Leukemia Cells; Characterization of Patient Heterogeneity. J. Pers. Med. 2021, 11, 779.
https://doi.org/10.3390/jpm11080779
AMA Style
Grønningsæter IS, Reikvam H, Aasebø E, Bartaula-Brevik S, Hernandez-Valladares M, Selheim F, Berven FS, Tvedt TH, Bruserud Ø, Hatfield KJ.
Effects of the Autophagy-Inhibiting Agent Chloroquine on Acute Myeloid Leukemia Cells; Characterization of Patient Heterogeneity. Journal of Personalized Medicine. 2021; 11(8):779.
https://doi.org/10.3390/jpm11080779
Chicago/Turabian Style
Grønningsæter, Ida Sofie, Håkon Reikvam, Elise Aasebø, Sushma Bartaula-Brevik, Maria Hernandez-Valladares, Frode Selheim, Frode S. Berven, Tor Henrik Tvedt, Øystein Bruserud, and Kimberley Joanne Hatfield.
2021. "Effects of the Autophagy-Inhibiting Agent Chloroquine on Acute Myeloid Leukemia Cells; Characterization of Patient Heterogeneity" Journal of Personalized Medicine 11, no. 8: 779.
https://doi.org/10.3390/jpm11080779
APA Style
Grønningsæter, I. S., Reikvam, H., Aasebø, E., Bartaula-Brevik, S., Hernandez-Valladares, M., Selheim, F., Berven, F. S., Tvedt, T. H., Bruserud, Ø., & Hatfield, K. J.
(2021). Effects of the Autophagy-Inhibiting Agent Chloroquine on Acute Myeloid Leukemia Cells; Characterization of Patient Heterogeneity. Journal of Personalized Medicine, 11(8), 779.
https://doi.org/10.3390/jpm11080779
